Nova Mentis (Germany) Performance
| HN3Q Stock | EUR 0.02 0.0001 0.45% |
Nova Mentis holds a performance score of 8 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -10.12, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Nova Mentis are expected to decrease by larger amounts. On the other hand, during market turmoil, Nova Mentis is expected to outperform it. Use Nova Mentis Life sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to analyze future returns on Nova Mentis Life.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nova Mentis Life are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Nova Mentis reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.1 M |
Nova |
Nova Mentis Relative Risk vs. Return Landscape
If you would invest 2.50 in Nova Mentis Life on August 27, 2024 and sell it today you would lose (0.28) from holding Nova Mentis Life or give up 11.2% of portfolio value over 90 days. Nova Mentis Life is generating 14.2069% of daily returns assuming 128.6148% volatility of returns over the 90 days investment horizon. Simply put, majority of traded equity instruments are less risky than Nova on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Nova Mentis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Mentis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nova Mentis Life, and traders can use it to determine the average amount a Nova Mentis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1105
| Best Portfolio | Best Equity | HN3Q | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 128.61 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Nova Mentis is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nova Mentis by adding it to a well-diversified portfolio.
Nova Mentis Fundamentals Growth
Nova Stock prices reflect investors' perceptions of the future prospects and financial health of Nova Mentis, and Nova Mentis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nova Stock performance.
| Return On Equity | -0.89 | |||
| Return On Asset | -0.52 | |||
| Current Valuation | 5.17 M | |||
| Shares Outstanding | 143.47 M | |||
| Price To Book | 4.41 X | |||
| Price To Sales | 4,602 X | |||
| EBITDA | (2.93 M) | |||
| Cash And Equivalents | 1.51 M | |||
| Cash Per Share | 0.01 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.95 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 881.16 K | |||
About Nova Mentis Performance
By analyzing Nova Mentis' fundamental ratios, stakeholders can gain valuable insights into Nova Mentis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nova Mentis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nova Mentis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nova Mentis Life Science Corp., through its subsidiaries, engages in the research and development of medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder in Canada. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. NOVA MENTIS is traded on Frankfurt Stock Exchange in Germany.Things to note about Nova Mentis Life performance evaluation
Checking the ongoing alerts about Nova Mentis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nova Mentis Life help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nova Mentis Life is way too risky over 90 days horizon | |
| Nova Mentis Life has some characteristics of a very speculative penny stock | |
| Nova Mentis Life appears to be risky and price may revert if volatility continues | |
| Nova Mentis Life has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (2.68 M) with loss before overhead, payroll, taxes, and interest of (5.44 K). | |
| Nova Mentis Life has accumulated about 1.51 M in cash with (1.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing Nova Mentis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nova Mentis' stock is overvalued or undervalued compared to its peers.
- Examining Nova Mentis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nova Mentis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nova Mentis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nova Mentis' stock. These opinions can provide insight into Nova Mentis' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Nova Stock analysis
When running Nova Mentis' price analysis, check to measure Nova Mentis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Mentis is operating at the current time. Most of Nova Mentis' value examination focuses on studying past and present price action to predict the probability of Nova Mentis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Mentis' price. Additionally, you may evaluate how the addition of Nova Mentis to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |